Cash Flow from Financial Activities: The net amount of cash transactions used in funding activities.
Apyx Medical Corporation (APYX) had Cash Flow from Financial Activities of $0.05M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$11.37M |
|
$-3.78M |
|
$4.29M |
|
$7.08M |
|
$13.95M |
|
$-2.57M |
|
$-1.11M |
|
$-3.69M |
|
$-3.69M |
|
$-3.74M |
|
$-3.74M |
|
$-3.74M |
|
$-3.74M |
|
$-2.57M |
|
$-2.44M |
|
40.73M |
|
40.73M |
|
$-0.09 |
|
$-0.09 |
|
| Balance Sheet Financials | |
$49.91M |
|
$2.05M |
|
$8.27M |
|
$58.19M |
|
$10.57M |
|
$34.39M |
|
$40.17M |
|
$50.73M |
|
$7.46M |
|
$7.46M |
|
$7.46M |
|
37.79M |
|
| Cash Flow Statement Financials | |
$-1.94M |
|
$-0.32M |
|
|
Cash Flow from Financial Activities |
$0.05M |
$31.74M |
|
$29.30M |
|
$-2.44M |
|
$0.97M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.72 |
|
-- |
|
-- |
|
0.82 |
|
4.61 |
|
62.28% |
|
-22.63% |
|
-22.63% |
|
-- |
|
-32.44% |
|
-33.22% |
|
$-2.25M |
|
-- |
|
-- |
|
-- |
|
0.20 |
|
0.52 |
|
1.01 |
|
89.01 |
|
-50.13% |
|
-50.13% |
|
-6.42% |
|
-8.93% |
|
$0.20 |
|
$-0.06 |
|
$-0.05 |
|